Cargando…
Speech treatment in Parkinson's disease: Randomized controlled trial (RCT)
BACKGROUND: As many as 89% of people with Parkinson's disease (PD) develop speech disorders. OBJECTIVES: This randomized controlled trial evaluated two speech treatments for PD matched in intensive dosage and high‐effort mode of delivery, differing in subsystem target: voice (respiratory‐laryng...
Autores principales: | Ramig, Lorraine, Halpern, Angela, Spielman, Jennifer, Fox, Cynthia, Freeman, Katherine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6261685/ https://www.ncbi.nlm.nih.gov/pubmed/30264896 http://dx.doi.org/10.1002/mds.27460 |
Ejemplares similares
-
Single Word Intelligibility of Individuals with Parkinson’s Disease in Noise: Pre-Specified Secondary Outcome Variables from a Randomized Control Trial (RCT) Comparing Two Intensive Speech Treatments (LSVT LOUD vs. LSVT ARTIC)
por: Schulz, Geralyn, et al.
Publicado: (2021) -
Immediate and long‐term effects of speech treatment targets and intensive dosage on Parkinson's disease dysphonia and the speech motor network: Randomized controlled trial
por: Narayana, Shalini, et al.
Publicado: (2022) -
LSVT LOUD and LSVT BIG: Behavioral Treatment Programs for Speech and Body Movement in Parkinson Disease
por: Fox, Cynthia, et al.
Publicado: (2012) -
The effects of intensive speech treatment on intelligibility in Parkinson's disease: A randomised controlled trial
por: Levy, Erika S., et al.
Publicado: (2020) -
Protocol for Correcting Residual Errors with Spectral, ULtrasound, Traditional Speech therapy Randomized Controlled Trial (C-RESULTS RCT)
por: McAllister, Tara, et al.
Publicado: (2020)